BJU Int

1. LU G, Wang J, Zheng W, Yu H, et al
   Immune checkpoint inhibitor nivolumab induces durable response in microsatellite instability-high and DNA damage repair-deficient metastatic castration-resistant prostate cancer.
   BJU Int. 2025 Nov 14. doi: 10.1111/bju.70084.
   

   >> Share

   
   

   
   BMC Cancer

2. LAPOINTE-BELLEAU A, Rouleau M, Villeneuve L, Descarreaux J, et al
   Androgenic effects of 11-oxyandrogens in castration-resistant prostate cancer.
   BMC Cancer. 2025;25:1786.
   

   >> Share

   
   

   
   BMC Urol

3. YANG Y, Cheng J, Liao X, Chen J, et al
   Outcomes of robotic prostatectomy with lymph node removal and early hormone therapy for locally advanced prostate cancer (pT3-4N0-1M0).
   BMC Urol. 2025;25:288.
   

   >> Share

   
   
4. WANG Y, Wang J
   Prostate cancer misdiagnosed as prostatic abscess: case report and literature review.
   BMC Urol. 2025;25:289.
   

   >> Share

   
   

   
   Br J Cancer

5. ZHU Y, Zarean E, Li DL, O'Reilly RL, et al
   Tumour-based epigenetic signatures as markers of prostate cancer aggressiveness after radical prostatectomy.
   Br J Cancer. 2025 Nov 20. doi: 10.1038/s41416-025-03257.
   

   >> Share

   
   
6. QIU C, Wang X, Francia G, Casiano CA, et al
   A panel of four autoantibodies to tumour-associated antigens in patients with prostate cancer and its potential for multi-cancer detection.
   Br J Cancer. 2025 Nov 18. doi: 10.1038/s41416-025-03242.
   

   >> Share

   
   

   
   Cancer Res

7. KUMAR R, Jonnatan S, Sanin DE, Vakkala V, et al
   Androgen receptor drives polyamine synthesis creating a vulnerability for prostate cancer.
   Cancer Res. 2025 Nov 21. doi: 10.1158/0008-5472.CAN-25-1532.
   

   >> Share

   
   

   
   Clin Cancer Res

8. MCHUGH D, Dallos M, Teo MY, McBride SM, et al
   Accelerating Drug Development in Hormone-Naive Prostate Cancer Through Multi-Modal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.
   Clin Cancer Res. 2025 Nov 20. doi: 10.1158/1078-0432.CCR-25-2679.
   

   >> Share

   
   

   
   Eur Urol

9. BERTOLO R, Antonelli A
   Re: Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled Trial.
   Eur Urol. 2025 Nov 14:S0302-2838(25)04793-1. doi: 10.1016/j.eururo.2025.
   

   >> Share

   
   

   
   Int J Cancer

10. JENSBY EF, Klingenberg S, Fredsoe J, Fonfara KE, et al
    Training and validation of a novel 14-gene expression signature associated with prostate cancer metastasis and postoperative recurrence.
    Int J Cancer. 2025 Nov 17. doi: 10.1002/ijc.70247.
    

    >> Share

    
    
11. FURLANO K, Keshavarzian T, Biernath N, Fendler A, et al
    Epigenomics-guided precision oncology: Chromatin variants in prostate tumor evolution.
    Int J Cancer. 2026;158:314-332.
    

    >> Share

    
    

    
    Int J Urol

12. HASHIZUME A
    Editorial Comment on Androgen Receptor Signaling Inhibitors in Nonmetastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study.
    Int J Urol. 2025 Nov 17. doi: 10.1111/iju.70262.
    

    >> Share

    
    

    
    J Nucl Med

13. GHEZZO S, Mapelli P, Cogrossi LL, Samanes Gajate AM, et al
    Diagnostic Accuracy of Fully Hybrid PET/MRI with [(68)Ga]Ga-PSMA-11 and [(68)Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard.
    J Nucl Med. 2025 Nov 20:jnumed.125.269782. doi: 10.2967/jnumed.125.269782.
    

    >> Share

    
    
14. WANG G, Lai Y, Chen D, Jin W, et al
    First-in-Human PET Imaging of Prostate Cancer Using [(68)Ga]Ga-AZ-093 and Its Nitroimidazole-Conjugated Derivative [(68)Ga]Ga-AZ-NI-093.
    J Nucl Med. 2025 Nov 20:jnumed.125.270703. doi: 10.2967/jnumed.125.270703.
    

    >> Share

    
    

    
    J Urol

15. ZELTSER N, Haas R, Ibilibor C, Gelfond J, et al
    Joint Biochemical & Genetic Prostate Cancer Risk Stratification.
    J Urol. 2025 Nov 21:101097JU0000000000004859. doi: 10.1097/JU.0000000000004859.
    

    >> Share

    
    
16. ALLEN R, Liu V, Chan JM, Graff R, et al
    Effect of Post-Diagnosis Diet and Lifestyle on Clinical Outcomes in Prostate Cancer Survivors: A Systematic Review.
    J Urol. 2025 Nov 21:101097JU0000000000004855. doi: 10.1097/JU.0000000000004855.
    

    >> Share

    
    
17. TINGEY S, Gangwish D, O'Neil B
    Data Grows in Support of Micro-Ultrasound for Prostate Cancer Diagnosis.
    J Urol. 2025 Nov 14:101097JU0000000000004818. doi: 10.1097/JU.0000000000004818.
    

    >> Share

    
    

    
    PLoS One

18. WANG X, Jiang A, Li C, Liu Z, et al
    Multi-omics analysis indicates an association between TAPBP and prostate cancer.
    PLoS One. 2025;20:e0336438.
    

    >> Share

    
    

    
    Prostate

19. MILLAN B, Pramod N, Blachman-Braun R, Saini J, et al
    Long-Term Follow-Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial.
    Prostate. 2025 Nov 16. doi: 10.1002/pros.70093.
    

    >> Share

    
    

    
    Urology

20. SMANI S, Wang R, Zhou X, Sprenkle PC, et al
    Area-Level Social Deprivation and Use of Prostate MRI Before Prostate Biopsy Among Commercial Insurance Beneficiaries.
    Urology. 2025;205:145-151.
    

    >> Share

    
    
21. ARENAS-GALLO C, Goldman M, Millot JC, McCann J, et al
    Increasing Utilization of Sedation for Prostate Biopsies: National Trends, Predictors, and Patient Cost.
    Urology. 2025;205:112-118.
    

    >> Share

    
    
22. CAHILL EM, de Oca EMM, Flores JM, Bennett NE, et al
    Knowledge and Attitudes Towards Fertility Preservation in Patients Undergoing Radical Prostatectomy.
    Urology. 2025;205:75-79.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share